Beyond the Biopsy: How AI Is Changing Skin Cancer Detection

A biopsy is still the gold standard for diagnosing skin cancer, but it is far from perfect. From the AOCD meeting in Orlando, Dr. Laura Ferris, Chair of Dermatology at the University of North Carolina, joins us to break down how skin cancer detection is evolving and why tools like dermoscopy, mole mapping, and total body photography are changing the way dermatologists evaluate suspicious lesions.We also explore the growing role of AI and FDA-cleared technologies like Nevisense and Dermasensor, plus the challenges of access to dermatology care, especially in rural communities. From smarter screening to reducing unnecessary biopsies, this episode looks at what the future of skin cancer detection could really look like.